Biodexa Pharmaceuticals Plc (BDRX)
1.09
-0.09
(-7.63%)
USD |
NASDAQ |
May 06, 16:00
1.03
-0.06
(-5.50%)
After-Hours: 17:41
Biodexa Pharmaceuticals Net Income (TTM): -8.826M for Dec. 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -8.826M |
| June 30, 2023 | -9.869M |
| December 31, 2022 | -9.251M |
| June 30, 2022 | -6.957M |
| December 31, 2021 | -7.517M |
| June 30, 2021 | -10.70M |
| December 31, 2020 | -27.90M |
| June 30, 2020 | -28.90M |
| December 31, 2019 | -12.98M |
| June 30, 2019 | -10.33M |
| Date | Value |
|---|---|
| December 31, 2018 | -20.21M |
| June 30, 2018 | -24.89M |
| December 31, 2017 | -20.88M |
| June 30, 2017 | -26.40M |
| December 31, 2016 | -26.64M |
| June 30, 2016 | -19.68M |
| December 31, 2015 | -15.39M |
| June 30, 2015 | -17.03M |
| December 31, 2014 | -14.24M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-28.90M
Minimum
Jun 2020
-6.957M
Maximum
Jun 2022
-13.32M
Average
-10.10M
Median
Net Income (TTM) Benchmarks
| Adaptimmune Therapeutics PLC | -113.87M |
| NuCana PLC | -34.32M |
| Autolus Therapeutics PLC | -208.38M |
| Mereo BioPharma Group PLC | -29.47M |
| Bicycle Therapeutics PLC | -180.66M |